- Home
- HOUR vs CLSD Comparison
HOUR vs CLSD Comparison
Compare HOUR & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- CLSD
- Stock Information
- Founded
- HOUR 2015
- CLSD 2011
- Country
- HOUR United States
- CLSD United States
- Employees
- HOUR N/A
- CLSD N/A
- Industry
- HOUR Catalog/Specialty Distribution
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- CLSD Health Care
- Exchange
- HOUR Nasdaq
- CLSD Nasdaq
- Market Cap
- HOUR 63.3M
- CLSD 68.4M
- IPO Year
- HOUR 2022
- CLSD 2016
- Fundamental
- Price
- HOUR $2.77
- CLSD $4.12
- Analyst Decision
- HOUR
- CLSD Hold
- Analyst Count
- HOUR 0
- CLSD 4
- Target Price
- HOUR N/A
- CLSD $65.00
- AVG Volume (30 Days)
- HOUR 399.0K
- CLSD 78.4K
- Earning Date
- HOUR 11-11-2025
- CLSD 11-11-2025
- Dividend Yield
- HOUR N/A
- CLSD N/A
- EPS Growth
- HOUR N/A
- CLSD N/A
- EPS
- HOUR 0.02
- CLSD N/A
- Revenue
- HOUR $138,441,228.00
- CLSD $4,166,000.00
- Revenue This Year
- HOUR N/A
- CLSD $98.20
- Revenue Next Year
- HOUR N/A
- CLSD $213.77
- P/E Ratio
- HOUR $128.51
- CLSD N/A
- Revenue Growth
- HOUR N/A
- CLSD N/A
- 52 Week Low
- HOUR $1.10
- CLSD $3.32
- 52 Week High
- HOUR $6.90
- CLSD $24.75
- Technical
- Relative Strength Index (RSI)
- HOUR 49.74
- CLSD 68.93
- Support Level
- HOUR $2.71
- CLSD $4.00
- Resistance Level
- HOUR $2.94
- CLSD $4.50
- Average True Range (ATR)
- HOUR 0.26
- CLSD 0.36
- MACD
- HOUR -0.08
- CLSD -0.04
- Stochastic Oscillator
- HOUR 15.11
- CLSD 51.57
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.